Futura Medical plc (AIM: FUM), the pharmaceutical company developing innovative sexual health products, today announces that it has been granted allowance of its EU patent which will provide protection for MED3000 until 2040 in all European markets. In all other key ED markets including the US, the Company is continuing to prosecute patent applications to provide […]